Zyme and Channelinsight have reached a resolution to their dispute regarding United States Patent No. 8,296,258 B2 (the "'258 Patent").
Channelinsight will not assert the '258 Patent or any patent in the '258 Patent family against Zyme or Zyme's existing or future customers. Channelinsight and Zyme look forward to competing in the marketplace.
About Zyme Zyme is the global leader in the emerging channel data management (CDM) space, delivering the intelligence global companies need to accelerate channel sales and improve ROI from incentive programs. Zyme's flexible, cloud-based offering simplifies data collection and helps companies such as Dell, Symantec, and Logitech liberate the valuable intelligence locked in their channel data. Zyme's solution increases sales by enabling channel executives to leverage real-time granular data from the channel, develop more effective partner segmentation, create better-targeted MDF, co-op, and rebate programs – and maintain a deeper understanding of customers, to improve regional sales performance and product planning. With a global channel directory of over 750,000 partners, support for a wide range of partner reporting formats, and a proven methodology for ensuring partner reporting compliance, Zyme's purpose-built CDM solution delivers results that home-grown custom systems cannot equal.